KR970000242A - 성인용 사람성장 호르몬제 - Google Patents

성인용 사람성장 호르몬제 Download PDF

Info

Publication number
KR970000242A
KR970000242A KR1019960025703A KR19960025703A KR970000242A KR 970000242 A KR970000242 A KR 970000242A KR 1019960025703 A KR1019960025703 A KR 1019960025703A KR 19960025703 A KR19960025703 A KR 19960025703A KR 970000242 A KR970000242 A KR 970000242A
Authority
KR
South Korea
Prior art keywords
growth hormone
human growth
adult
ability
kilodalton
Prior art date
Application number
KR1019960025703A
Other languages
English (en)
Inventor
노리아키 아시다
미와 이케다
마사루 본죠
카즈토시 호리코미
타케시 카미오카
Original Assignee
사토 아키오
미쯔이도오아쯔가가꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사토 아키오, 미쯔이도오아쯔가가꾸 가부시기가이샤 filed Critical 사토 아키오
Publication of KR970000242A publication Critical patent/KR970000242A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

본 발명은, 체성분개선능, 지방분해촉진능 및/또는 핼중 IGF-I 농도상승능을 가진 성인용 사람성장호르몬제의 제공을 과제로한 것이며, 또 본 발명은, 천연형 20킬로 돌턴 사람성장호르몬을 유효성분으로서 함유하는, 내장능이상유발능이 낮은, 성인, 특히 성인의 성장호르몬 결손증 환자에 대한 성인보충요법용 사람성장 호르몬제를 제공하는 것을 목적으로 한 것이며, 그 구성에 있어서, 20킬로 돌턴 성장호르몬을 유효성분으로서 함유하는 성인보충요법용 성장호르몬제인 것을 특징으로 한 것이다.

Description

성인용 사람성장 호르몬제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 천연형 20킬로 돌턴 사람성장 호르몬을 유효성분으로서 함유하는 것을 특징으로 하는 성인용 사람성장 호르몬제.
  2. 제1항에 있어서, 천연형 20킬로 돌턴 사람성장 호르몬이 배열표의 배열번호 1 또는 배열번호 2에 기재의 아미노산배열을 가진 천연형 20킬로 돌턴 사람성장 호르몬인 것을 특징으로 하는 성인용 사람성장 호르몬제.
  3. 제1항 또는 제2항에 있어서, 성인에 대해서 체성분 개선능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
  4. 제1항 또는 제2항에 있어서, 성인에 대해서 지방분해 촉진능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
  5. 제1항 또는 제2항에 있어서, 성인에 대해서 혈중 인슐린모양 성장인자- Ⅰ농도상승능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
  6. 제1항에 있어서, 성인보충요법용인 것을 특징으로 하는 성인용 사람성장 호르몬제.
  7. 제6항에 있어서, 천연형 20킬로 돌턴 사람성장 호르몬이 배열표의 배열번호 1 또는 배열번호 2에 기재의 아미노산배열을 가진 천연형 20킬로 돌턴 사람성장 호르몬인 것을 특징으로 하는 성인용 사람성장 호르몬제.
  8. 제6항 또는 제7항에 있어서, 성인의 성장호르몬 결손환자에 대하여 체성분 개선능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
  9. 제6항 또는 제7항에 있어서, 성인의 성장호르몬 결손증 환자에 대해서 지방분해촉진능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
  10. 제6항 또는 제7항에 있어서, 성인의 성장호르몬 결손증 환자에 대해서 혈중 인슐린모양 성장인자- Ⅰ농도상승능을 가진 것을 특징으로 하는 성인용 사람성장 호르몬제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960025703A 1995-06-29 1996-06-29 성인용 사람성장 호르몬제 KR970000242A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP16357295 1995-06-29
JP95-163572 1995-06-29
JP95-316883 1995-12-05
JP31688395 1995-12-05

Publications (1)

Publication Number Publication Date
KR970000242A true KR970000242A (ko) 1997-01-21

Family

ID=26488968

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960025703A KR970000242A (ko) 1995-06-29 1996-06-29 성인용 사람성장 호르몬제

Country Status (5)

Country Link
US (1) US6399565B1 (ko)
EP (1) EP0753307A3 (ko)
KR (1) KR970000242A (ko)
CN (1) CN1145808A (ko)
NZ (1) NZ286884A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210107765A (ko) * 2019-02-15 2021-09-01 히다찌 겐끼 가부시키가이샤 건설 기계

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760187A (en) * 1996-02-22 1998-06-02 Mitsui Toatsu Chemicals, Inc. Purification process of a human growth hormone
US7611700B2 (en) * 2002-09-09 2009-11-03 Hanall Pharmaceuticals, Co., Ltd. Protease resistant modified interferon alpha polypeptides
WO2005018659A2 (en) * 2003-08-20 2005-03-03 Neuren Pharmaceuticals Limited Somatogenic therapy using a 20kda placental variant of growth hormone
EP1778269A4 (en) * 2004-07-23 2009-09-23 Neuren Pharmaceuticals Ltd NON-DIABETOGENIC THERAPY USING 20KDA PLACENTAL GROWTH HORMONE VARIANT
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
KR101719350B1 (ko) * 2008-12-25 2017-03-23 가부시키가이샤 한도오따이 에네루기 켄큐쇼 반도체 장치 및 그 제작 방법
ES2861059T3 (es) * 2015-09-08 2021-10-05 Japan Chem Res Nuevo mutante de la seroalbúmina humana

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618697A (en) 1982-12-10 1997-04-08 Novo Nordisk A/S Process for preparing a desired protein
JPS6384500A (ja) * 1986-09-30 1988-04-15 Kunio Nakajima ヒト２０ｋ成長ホルモンの製造方法
US5496713A (en) * 1992-09-09 1996-03-05 Mitsui Toatsu Chemicals, Inc. Process for producing 20 kD human growth hormone
NZ286241A (en) * 1995-03-29 1997-11-24 Mitsui Chemicals Inc Method of producing a peptide as a fusion protein intracellularly which is cleaved on passing the cell membrane

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210107765A (ko) * 2019-02-15 2021-09-01 히다찌 겐끼 가부시키가이샤 건설 기계

Also Published As

Publication number Publication date
EP0753307A2 (en) 1997-01-15
CN1145808A (zh) 1997-03-26
EP0753307A3 (en) 1999-06-09
NZ286884A (en) 1997-12-19
US6399565B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
CA1277599C (en) Vanadium - peroxide compositions as insulin mimickers
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
ATE203165T1 (de) Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndromes
GB9316895D0 (en) Hepatoselective insulin analogues
MY125556A (en) Aqueous formulations of peptide
HK1107103A1 (en) Purification and stabilization of peptide and proteins in pharmaceutical agents
WO1999012561A3 (en) FRACTURE HEALING USING PTHrP ANALOGS
CA2158058A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
BR9608799A (pt) Análogo pro-grf corpo graxo quimérico com aumentada potência biológica, formulação farmacêutica, e, processos para o aumento do nìvel de hormÈnio de crescimento, para o diagnóstico de deficiências de hormÈnio de crescimento, para o tratamento de retardo do crescimento ou ananismo pituitário, de ferida ou cicratização de ossos e de osteoporose em um paciente, e, para melhoria do anabolismo de proteìna em humanos ou animais.
EP0590156A4 (en) Novel, physiologically active protein and hemopoietic stem cell growth promoter
KR950701818A (ko) 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues)
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
KR970000242A (ko) 성인용 사람성장 호르몬제
KR960702847A (ko) 생물학적 활성의 바소프레신 유사체
EP0416678B1 (en) Topical compositions containing Defibrotide
KR960000921A (ko) 칼시토닌 유도체 및 그 용도
EP0630651A3 (en) Semi-solid drugs and processes for their manufacture.
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
SE9201584D0 (sv) Use of alpha-ketoglutarate
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
JPS56156211A (en) Preparation of stable allantoin pharmaceutical
IL145403A0 (en) Fragments of virus protein 2 or 3 of the polyoma virus, use for transporting active ingredients
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
N231 Notification of change of applicant
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
B601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19990730

Effective date: 20010331

Free format text: TRIAL NUMBER: 1999101002754; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19990730

Effective date: 20010331

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

Free format text: TRIAL NUMBER: 2001201002863; APPEAL AGAINST DECISION TO DECLINE REFUSAL

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010501

Effective date: 20020329

Free format text: TRIAL NUMBER: 2001201002863; JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010501

Effective date: 20020329